Mode
Text Size
Log in / Sign up

Stress Urinary Incontinence

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Stress Urinary Incontinence

58 trials tracked for Stress Urinary Incontinence: 11 in phase 3 or 4 and 8 with published results. The most-cited published study has 148 citations.

58Trials tracked
11Phase 3 & 4
0Recruiting
8With published results
Phase distribution
Phase 4 3 Phase 3 8 Phase 2 8 Phase 1 1 Other / NA 38
  1. Phase 3 ATLAS: Ambulatory Treatments for Leakage Associated With Stress Completed · 148 cited
  2. Phase 3 Combined Treatment for Mixed Incontinence Completed · 83 cited
  3. Phase 3 Study Comparing TVT With TVT-SECUR for the Treatment of Stress Urinary Incontinence Completed · 74 cited
  4. Phase 3 Autologous Muscle Derived Cells for Female Urinary Sphincter Repair Completed · 44 cited
  5. Phase 3 Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery Completed · 30 cited
  6. Phase 3 Sling vs Botox for Mixed Incontinence Completed · 13 cited
Show 44 more trials
  1. Phase 3 Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study Completed · 12 cited
  2. Phase 4 The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence Completed · 10 cited
  3. Phase 4 Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence Completed
  4. Phase 4 The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling Completed
  5. Phase 3 Platelet-Rich Plasma for Stress Urinary Incontinence Completed
  6. Phase 2 Safety and Efficacy Study on the Implantation of the Tension-Free Vaginal Tape (TVT-Secur) Under Local Anesthesia Completed
  7. Phase 2 GTx-024 as a Treatment for Stress Urinary Incontinence in Women Completed
  8. Phase 2 An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence Completed
  9. Phase 2 Gentamicin Intravesical Efficacy for Infection of Urinary Tract Completed
  10. Phase 2 Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence Completed
  11. Phase 2 Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients Completed
  12. Phase 2 Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence Completed
  13. Phase 2 Autologous Cell Therapy for Female Stress Urinary Incontinence Completed
  14. Phase 1 Does Single Dose Imipramine Affect the Opening Pressure of the Urethral and Anal Sphincter? Completed
  15. N/A Comparing KIM to TVT Exact Sling Completed
  16. N/A Stress Incontinence Trial With Elitone Device Completed
  17. N/A Artificial Urinary Sphincter Clinical Outcomes Completed
  18. N/A Time Interval Between TVT and First Void (TIBT) Study Completed
  19. N/A Randomized Control Trial to Assess Postoperative Pain After Sling Placement Completed
  20. N/A A Post-Market Study of the AMS AdVance™ Male Sling System for the Treatment of Male Stress Urinary Incontinence Completed
  21. N/A Efficacy of Electroacupuncture (EA) for Women With Pure Stress Urinary Incontinence (SUI) Completed
  22. N/A AMS AdVance and AdVance XP Male Sling Systems for the Treatment of Stress Urinary Incontinence Following Prostatectomy: Evaluation of Safety, Efficacy, and Quality of Life Through Retrospective Chart Review and Prospective Follow-up Completed
  23. N/A Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial Completed
  24. N/A A Randomized Controlled Trial of the Uresta Continence Pessary Completed
  25. N/A Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms Completed
  26. N/A Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence Completed
  27. N/A Laser Therapy for Treatment of Urogenital Symptoms in Women Completed
  28. N/A A Group-Based Therapeutic Yoga Intervention for Urinary Incontinence in Ambulatory Older Women Completed
  29. N/A Comparison of the Viveve Treatment and Cryogen-Only Treatment Versus Sham Treatment for Stress Urinary Incontinence Completed
  30. N/A The Altis® Single Incision Sling System for Female Stress Urinary Incontinence Study Completed
  31. N/A Systematized Quality Exercise Alternatives for Stress Incontinence Completed
  32. N/A The Prefyx PPS™ System eRegistry Completed
  33. N/A Transobturator Verus Single Incision Slings Completed
  34. N/A TVT-SECUR as an Office-based Procedure Completed
  35. N/A LIBERATE International Completed
  36. N/A RCT on Multimodal Self-treatment for Women With Incontinence Using a Digital Health Application Completed
  37. N/A A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence Completed
  38. N/A Educating Women About Pelvic Floor Disorders During Pregnancy Completed
  39. N/A Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery Completed
  40. N/A Retropubic vs. Single-Incision Mid-Urethral Sling for Stress Urinary Incontinence Completed
  41. N/A A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence Completed
  42. N/A Disposable Stress Urinary Incontinence Pessary Device Study Completed
  43. N/A Use of the Leva Incontinence System in Treating Bladder Incontinence. Completed
  44. N/A Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence Completed

Showing the 50 most-cited and recently-updated of 58 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Stress Urinary Incontinence: what the trials found

Several surgical and procedural interventions have been evaluated for Stress Urinary Incontinence (SUI). A midurethral sling demonstrated significant reductions in UDI total scores (-138.8 to -147.7), stress scores (-69.3 to -73.8), and irritative scores (-49.5 to -53.5) 5. Tension-free vaginal tape was evaluated, showing a subjective cure rate of 72% to 77% at 12 months 6, though patient global impression improvements were not statistically significant 6. The AMDC-USR procedure showed response rates of 82% and 90% at 12 months 10.

Pharmacological and injectable treatments show varying results. Botox injections resulted in reductions in UDI-LF total scores (-63.1 to -89.1), stress scores (-20.2 to -46.4), and irritative scores (-28.1 to -40.8) 9. Iltamiocel was associated with a 50% reduction in SUI episode frequency in 103 participants compared to 52 in the comparison group at 12 months 7, with 73 vs 30 achieving a 75% reduction 7. Behavioral therapy showed significant improvement, with 59-80 patients reporting 'Much Better' or 'Very Much Better' on PGI-I at both 3 and 12 months 4, and 49-71 patients reporting no bothersome SUI symptoms at 3 months 4.

Other interventions include lidocaine with epinephrine 1, liposomal bupivacaine (which showed a significant reduction in 'Pain in the Morning' from 9.5 to 27.0, p=0.014) 3, and platelet-rich plasma injections 11. The GTx-024 treatment was associated with an 81% mean percent change in SUI episodes per day and a 71% mean percent change in pad weight 14.

Recent results — preliminary, needs further review

  • Intravenous fluid administration showed a significant difference in residual bladder volume (141 vs 42, p=0.02) 21.
  • Laparoscopic Burch Colposuspension was evaluated as an intervention 22.

For the clinician treating this condition

  • Surgical interventions like midurethral slings and AMDC-USR show consistent improvements in UDI scores and response rates.
  • Behavioral therapy is associated with significant patient-reported improvement in SUI symptoms at 3 and 12 months.
  • Injectable treatments (Botox, Iltamiocel) and specific pharmacological agents (GTx-024) show measurable impacts on incontinence frequency and score reductions.

AI synthesis of 12 cited trials, updated Jun 23, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.